Genitourinary Cancers | Specialty

Desert Harmony: Urological Associates of Southern Arizona Strives for Collaborative Cancer Care

August 13th 2012

At Urological Associates of Southern Arizona, "collaboration" is not just a buzzword, it's part and parcel of the daily practice.

Urology Practice Management Peer Exchange

August 10th 2012

Investigating Large and Small Urology Practice Intricacies

August 10th 2012

Balancing Quality of Care and Costs in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part I

August 10th 2012

Bone Health Programs in Urology Practices, Part II

August 10th 2012

Introduction to Urologists in Cancer Care Peer Exchange

August 10th 2012

Bone Health Programs in Urology Practices, Part I

August 10th 2012

Management of Oncology Care in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part II

August 10th 2012

Studies Support Efficacy of Axitinib as First- and Second-Line Kidney Cancer Treatment

July 30th 2012

Research presented at ASCO 2012 demonstrated the efficacy of axitinib (Inlyta) as both a first- and second-line treatment in patients with metastatic renal cell carcinoma.

Tivozanib Improves PFS Versus Sorafenib in Patients With Renal Cell Carcinoma

July 24th 2012

Tivozanib increased progression-free survival and objective response rate in patients with renal cell carcinoma compared with sorafenib.

The Urology Group: Balancing Expansion With Commitment to the Community

July 13th 2012

In tough economic times when many medical practices have scaled back or even shut down, The Urology Group has flourished.

Dr. Concepcion Discusses Urologists Treating Cancer

July 12th 2012

Dr. Raoul Concepcion, from Urology Associates, PC, Discusses Urologists Treating Cancer.

Bone Health Programs in Urology Practices Deliver Continuity of Care

July 12th 2012

Spurred by the desire to provide the full spectrum of care to prostate cancer patients, urologists across the country have begun to integrate bone health clinics into their practices.

EHRs in the Urology Office

July 11th 2012

The implementation of electronic health records to replace paper charts in urology practices is a recent phenomenon that is picking up some serious momentum.

The Therapeutic Landscape of Metastatic Renal Cell Carcinoma in 2012

July 9th 2012

In the last seven years, since the introduction of the targeted therapies, remarkable progress has transpired that has transformed the therapeutic landscape for metastatic renal cell carcinoma.

Case-Based Discussion: Sequencing Prostate Cancer Therapy

July 3rd 2012

Case-based discussion on sequencing prostate cancer therapies for a 72-year-old man with a metastatic adenocarcinoma with small-cell components, a PSA score of 80, and a Gleason score of 10.

High Points and Hurdles: Immunotherapy Moves Forward

June 27th 2012

Immunotherapy is maintaining its momentum in clinical development programs, with explorations under way in many tumor types, including breast and lung cancers previously considered poor candidates for such modalities.

NSAIDs and Statins Have No Impact on Renal Cell Carcinoma Risk

June 26th 2012

New data appears to undercut prior research by suggesting that neither NSAIDs nor statins influence the development of renal cell carcinoma.